1AE
Asset Logo

Aurora Energy Metals Limited

🇦🇺 ASX

⛏️ MINING

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-29.41%
Annual Growth

3 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

3
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Aurora Energy Metals Ltd. engages in the exploration and development of mining properties. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2022-05-18. The AUP is located in Malheur County, Oregon, approximately 16 kilometers (km) northwest of the town of McDermitt, Nevada. The Company’s wholly owned subsidiary, Oregon Energy LLC, holds 100% of the Project as well as surrounding mining claims that extend to the west and to the south-east, across the Oregon/Nevada border. The mining claims are located on public lands in Oregon and Nevada and on a contiguous Company-owned block of private land in Nevada. The land tenure comprises approximately 451 unpatented lode mining claims and 71 unpatented placer mining claims in Malheur County, Oregon and 31 unpatented placer mining claims in Humboldt County, Nevada. The total area covered by these claims is approximately 43 square kilometers. The Project area is covered with a thin veneer of alluvium overlying lakebed sediments.

📈 Performance

Price History

-76.50%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.05

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in 1AE

3

📊 Total Capital Earnings

$11K

🔃 Average investment frequency

16 weeks

💵 Average investment amount

$14,354

Last time a customer invested in 1AE

161 days
1AE investor breakdown
💵 Income of investors

More than 200k

150k - 200k

33%

100k - 150k

50k - 100k

33%

Less than 50k

33%
👶 Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
🙋 Legal gender of investors

Female

33%

Male

67%

Pearlers who invest in 1AE also invest in...

Pilbara Minerals Limited

PLS

Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum (tpa) lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.

🙌 Performance (5Yr p.a)

161.01%

📊 Share price

$2.15 AUD

⛏️ MINING

Find Out More

Liontown Resources Ltd. engages in the exploration and evaluation of minerals. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-12-27. The firm controls two major hard rock lithium deposits. The firm's projects include Kathleen Valley Project and Buldania Project. The Kathleen Valley Project is located in an established mining region about 60 kilometers north of Leinster and 680 kilometers north-east of Perth, Western Australia. The Kathleen Valley Lithium Project is a Tier-1 battery metals asset with excellent grade and scale in one of world's best mining districts. The Buldania Project is in the Eastern Goldfields Province of Western Australia, approximately 600 kilometers east of Perth. The Project is close to major road and rail infrastructure with direct access to the Port of Esperance 200 kilometers to the south. The firm's downstream expansion project includes investigating the potential for an integrated refinery to upgrade its spodumene from the Kathleen Valley mine to higher value lithium products.

🙌 Performance (5Yr p.a)

127.08%

📊 Share price

$0.54 AUD

⛏️ MINING

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

3.79%

📊 Share price

$68.90 AUD

🌏 GLOBAL

⛳️ DIVERSIFIED

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

🙌 Performance (5Yr p.a)

12.84%

📊 Share price

$16.09 AUD

🌏 GLOBAL

🤖 TECHNOLOGY

📈 HIGH PRICE GROWTH

⛳️ DIVERSIFIED

BHP

BHP

BHP Group Ltd. engages in the exploration, development, production and processing of iron ore, metallurgical coal, and copper. The company is headquartered in Melbourne, Victoria and currently employs 39,729 full-time employees. The firm is a producer of commodities, including iron ore, copper, nickel, potash and metallurgical (steelmaking) coal. The company is focused on offering a range of resources, which provides copper for renewable energy; nickel for electric vehicles; potash for sustainable farming, and iron ore and metallurgical coal for the steel needed for global infrastructure and the energy transition. Its segments include Copper, Iron Ore, and Coal. Its Copper segment is engaged in mining of copper, silver, zinc, molybdenum, uranium, and gold. Its Iron Ore segment is engaged in mining of iron ore. Its Coal segment is engaged in mining of metallurgical coal and energy coal. The firm is also focused on operating Olympic Dam, Prominent Hill, and Carrapateena underground copper-gold mines in South Australia. Its operations are situated in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and others.

🙌 Performance (5Yr p.a)

2.85%

📊 Share price

$39.90 AUD

💰 HIGH DIVIDEND

⚖️ HIGH GOVERNANCE

⛏️ MINING

Want more shares? Try these...

Algorae Pharmaceuticals Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The firm is actively engaged in expanding its therapeutic pipeline using a proprietary artificial intelligence (AI) drug discovery and development platform, known as Algorae Operating System (AlgoraeOS). The AI platform leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. By employing machine learning, deep learning, and neural networks, the AlgoraeOS is focused on uncovering synergistic fixed dose drug combinations that lead to the development of effective treatments for any medical condition. The company is also focused on advancing its drug candidates, which include AI-116 for the treatment of neurodegenerative disorders and/or dementia, and AI-168 for cardiovascular disease and NTCELL for Parkinson’s disease.

🙌 Performance (5Yr p.a)

-11.25%

📊 Share price

$0.01 AUD

🧬 BIOTECHNOLOGY

1414 Degrees Ltd. engages in the development, design, and manufacture of thermal energy storage systems. SiBox delivers high temperature carbon free industrial heat by harnessing the extremely high latent heat capacity of silicon. This enables intermittent renewables to provide flexible, ultra-high temperature heat 24/7 for industrial applications and to deliver reliable heat and power supply when required. The company is envisaged that the flexibility of the SiBox modular development concept provides a decarbonization pathway for energy users, such as high temperature industrial customers, mineral processing industries, thermal power stations and those needing a combined heat and power solution. The company is also developing the Aurora Energy Project located near Port Augusta, South Australia. The focus of the project is to develop a hybrid renewable energy project delivering reliable electricity to the region and national electricity market.

🙌 Performance (5Yr p.a)

-17.44%

📊 Share price

$0.03 AUD

🔨 COMMERCIAL SERVICES & SUPPLIES

AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The firm uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The firm's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. The company is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. The company co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.

🙌 Performance (5Yr p.a)

-17.48%

📊 Share price

$0.01 AUD

🧬 BIOTECHNOLOGY

Compare
Add to watchlist